Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck.

Gilbert J, Cmelak A, Shyr Y, Netterville J, Burkey BB, Sinard RJ, Yarbrough WG, Chung CH, Aulino JM, Murphy BA
Cancer. 2008 113 (1): 186-92

PMID: 18484593 · DOI:10.1002/cncr.23545

MeSH Terms (15)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Camptothecin Carcinoma, Squamous Cell Cisplatin Drug Administration Schedule Female Head and Neck Neoplasms Humans Irinotecan Male Middle Aged Neoplasm Metastasis Neoplasm Recurrence, Local

Connections (1)

This publication is referenced by other Labnodes entities: